TrialScope to Sponsor and Present at CBI’s 5th Annual Clinical Data Disclosure and Transparency Conference
Global leader in clinical trial transparency and compliance solutions will present at multiple sessions during industry-leading conference on topics of compliance and disclosure
Jersey City, NJ – January 30, 2018 – TrialScope, the global leader in clinical trial transparency and compliance solutions, announced today that its Director of Product Management, Francine Lane, and Chief Strategy Officer, Thomas Wicks, will both deliver presentations at CBI’s Fifth Annual Clinical Data Disclosure and Transparency Conference. The Company is also a sponsor of the conference, which takes place on January 30-31, 2018, in Philadelphia.
TrialScope executives will participate in three speaking sessions at the conference, designed to help sponsors navigate the complexities that accompany increasing regulatory requirements around data disclosure and transparency.
January 30 2018
Navigate FDAAA 801 Final Rule Implementation and Compliance, 2:15pm
- Francine Lane will deliver a presentation titled “Navigate FDAAA 801 Final Rule Implementation and Compliance” at 2:15pm. Her session will explore the law’s requirements and discuss best procedural practices for registration and submission procedures and cross-functional information flow.
January 31, 2018
Navigate Varying Regulatory Requirements for Plain Language Summaries, 11:30am
- Thomas Wicks, alongside three industry colleagues, will participate in this panel, which will explore the latest pressing topic in trial disclosure, plain language summaries.
Evolving Beyond Compliance — Moving the Needle on Transparency and Disclosure Initiatives, 12:15pm
- Wicks will present on the trends of trial transparency beyond regulatory requirements, the drivers for disclosing additional data, and the organizational approaches to implementing a more expansive transparency policy.
“Regulatory requirements around data disclosure and transparency are changing both in the U.S. and internationally,” explained Wicks. “I am excited to address these issues and deliver actionable insights for attendees, as pressure for sponsors to evolve their transparency initiatives, beyond mere compliance, continues to increase.”
For more information on CBI’s Publication and Clinical Data Disclosure and Transparency Conference, and the full schedule of speakers, visit: http://www.cbinet.com/conference/pc18257
To learn more about compliance and disclosure, visit TrialScope at www.TrialScope.com
TrialScope simplifies the complexities of clinical trial transparency. TrialScope’s award-winning, proven solutions have been implemented successfully and rigorously tested in the most complex environments and are managing disclosures for sponsors that are responsible for over 35% of industry sponsored clinical trials posted on clinicaltrials.gov. The company’s market-driven solutions and expertise enable sponsors to improve performance, mitigate compliance risk, and ultimately optimize efficiencies with clinical content lifecycle management tools, expertise and processes. TrialScope technologies are offered via a validation-ready SaaS platform hosted in a private cloud.